Pleuropulmonary Blastoma (PPB) is very rare and there is no established "standard" or "best"
therapy. For many years, children with PPB around the world have been treated according to
decisions made case-by-case in many different hospitals by many different physicians. No
treatment has been tested in a large group of PPB patients.
The goal is to treat many children with one treatment program and to learn the results of the